VRCA Projected Dividend Yield
Verrica Pharmaceuticals Inc ( NASDAQ : VRCA )Verrica Pharmaceuticals Inc. is a dermatology therapeutics company. Co. is focused on developing and commercializing treatments for skin diseases. Its product pipeline consists of three product candidates: YCANTH, VP-315 and VP-103. YCANTH is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin. Co. are also developing YCANTH for potential follow-on indications for the treatment of common warts and external genital warts. In addition, the Co. is also developing YCANTH for the treatment of external genital warts, or external genital warts EGW. 21 YEAR PERFORMANCE RESULTS |
VRCA Dividend History Detail VRCA Dividend News VRCA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |